Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-10-22

Clinical Trial Update: To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After Taking [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed how different doses of tadalafil influence the ability to obtain and sustain an erection 26 or 36 hours after dosing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cialis (tadalafil)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Impotence | Phase 3 | Status: COMPLETED